Year 2011
Area Healthcare and Medical

ImmuneXcite developed a disease and cancer therapy by enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.

Compound to enhance immune stimulation

This company was a spinout of the 2007 project, Compound to enhance immune stimulation.

Watch the CSO and co-founder, Ifat Rubin-Bejerano, present the ImmunExcite story at IdeaStream 2015.